Ex vivo human placental transfer and the vasoactive properties of hydralazine

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 1 I, 2000, Pages 167-169

  Magee, Kevin P ^a   Bawdon, Roger E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Hydralazine; Maternal fetal transfer; Vasoactive effects

Indexed keywords

HYDRALAZINE;

ARTICLE; DRUG DIFFUSION; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; PERFUSION PRESSURE; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL;

EID: 0033955750     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(00)70508-4     Document Type: Article

References (7)

1. EG Spokas G Folco J Quilley P Chander JC McGiff Endothelial mechanism in the vascular action of hydralazine Hypertension 5 2 Pt 2 1983 I107 I111
2. SL Pedron DL Reid JM Barnard JB Henry TM Phernetton JH Rankin Differential effects of intravenous hydralazine on myoendometrial and placental blood flow in hypertensive pregnant ewes Am J Obstet Gynecol 167 1992 1672 1678
3. J Allen K Skajaa S Maigaard A Forman Effects of vasodilators on isolated human uteroplacental arteries Obstet Gynecol 77 1991 765 771
4. H Schneider A Huch Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation Contrib Gynecol Obstet 13 1985 40 47
5. JC Challier Criteria for evaluating perfusion experiments and presentation of results Contrib Gynecol Obstet 13 1985 32 39
6. S Lindeberg B Holm P Lundborg CG Regårdh B Sandström The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women Eur J Clin Pharmacol 35 1988 131 135
7. LB Lacagnin HD Colby JP O’Donnell Separation and quantitation of hydralazine metabolites by high-performance liquid chromatography J Chromatogr 377 1986 319 327